Inovio Pharmaceuticals (NYSE:INO) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as joint bookrunning managers for the offering. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $3.33 in last session, and closed at $3.42, while the day range of stock is $3.20 -$3.48. The stock showed a positive weekly performance of 17.93%.
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) had its price target raised by analysts at Oppenheimer from $90.00 to $99.00. They now have an “outperform” rating on the stock. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $73.48, in last session and closed at $67.47, by losing -9.08%. The 52 week range of the stock is $26.80 – $80.25. Company’s market capitalization is $4.08 billion.
Shares of BioScrip Inc (NASDAQ:BIOS) a provider of home care services and pharmacy benefit management services in the U.S., tumbled by as much as 13% after the company reported disappointing fourth-quarter earnings results. BioScrip Inc (NASDAQ:BIOS) stock decreased -12.32% and finished the last session at $7.40. The EPS of the stock remained -0.61. Company’s market capitalization is $504.01 million.
Dyax Corp. (NASDAQ:DYAX) traded down 6.1% during trading on Thursday following insider selling activity, American Banking and Market News reports. Dyax Corp. (NASDAQ:DYAX) stock opened the session at $10.28, and closed the session at $10.20. The 52 week range of the stock remained $2.26 – $10.99 and the day range was $9.65 – $10.47.